In support of Rare Disease Day, our new whitepaper illuminates how actionable social insights through social listening can fill in the real-world gaps where clinical trials and traditional research methods fall short.
With over 7,000 identified rare diseases, it is estimated that at least 1 in 17 people are living with some form of rare health condition. Alarmingly, there is no cure for at least 90% of these diseases. So, what is preventing pharmaceutical companies from innovating within this therapeutic area? A key struggle companies face is lack of available data. Since the number of patients with each rare disease is so small, there are logistical difficulties at every step of the drug lifecycle – from designing clinical trials and recruiting participants, to employing effective marketing strategies. Fortunately, there is a simple solution to overcoming these challenges: harnessing actionable insights through social data. Download a free copy of our whitepaper to learn how social listening can impact your Rare Disease strategy and increase commercial success. Optimise your Rare Disease Strategy with Social Data Insights
Discover how social listening can impact your Rare Disease strategy and increase commercial success
Key questions answered by the whitepaper:
